Current status in diabetic macular edema treatments

doi:10.4239/wjd.v4.i5.165

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 5

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3931)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

491

HTML

2411

Sum=2902

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

485

Download

544

Sum=1029

Oct 15, 2013 (publication date) through Apr 25, 2024

Times Cited of This Article

Times Cited (21)

Journal Information of This Article

Publication Name

World Journal of Diabetes

ISSN

1948-9358

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Diabetes. Oct 15, 2013; 4(5): 165-169
Published online Oct 15, 2013. doi: 10.4239/wjd.v4.i5.165

Current status in diabetic macular edema treatments

Pedro Romero-Aroca

Pedro Romero-Aroca, Ophthalmology Service, Hospital Universitari Sant Joan, IISPV, Universidad Rovira i Virgili, 43203 Reus, Spain

Author contributions: Romero-Aroca P solely contributed to this paper.

Correspondence to: Pedro Romero-Aroca, MD, PhD, Professor, Ophthalmology Service, Hospital Universitari Sant Joan, IISPV, Universidad Rovira i Virgili, C/Ample 55 1º, 43203 Reus, Spain. romeropere@gmail.com

Telephone: +34-977-310300 Fax: +34-977-32375

Received: June 21, 2013
Revised: July 21, 2013
Accepted: September 18, 2013
Published online: October 15, 2013

Core Tip

Core tip: Diabetic macular edema is the leading causes of decreased visual acuity in diabetic patients, being the most important blindness causes in young adult people. New treatments have been developed in the last years, intravitreal anti-vascular endothelial growth factor drugs, corticoid intravitreal implants or injections, but the laser photocoagulation being the gold standard of diabetic macular edema treatment. The following manuscript tries to clarify the current status of diabetic macular edema treatment.